✦ LIBER ✦

Non-clinical development of anticancer drugs: Safety considerations

✍ Scribed by Paolo Colombo; Marina Cattoni; Guido Di Gallo; Romana Pulci; Marco Brughera

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulatory considerations for preclinica

✍ Joseph J. DeGeorge; Chang-Ho Ahn; Paul A. Andrews; Margaret E. Brower; Diana W. 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 193 KB

Non-invasive MRS in new anticancer drug

✍ Paul Workman; Ross J. Maxwell; John R. Griffiths 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

Oral delivery of anticancer drugs I: gen

✍ Mazzaferro, Silvia; Bouchemal, Kawthar; Ponchel, Gilles 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 362 KB

Non-clinical development of cancer vacci

✍ Monika Chabicovsky; Peter Ryle 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 302 KB

The development of new anticancer drugs

✍ F. M. Arcamone 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 259 KB

Clinical anticancer drug development: ta

✍ Benson, C; Kaye, S; Workman, P; Garrett, M; Walton, M; de Bono, J 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB